Topical Ruxolitinib in the Treatment of Necrobiosis Lipoidica: A Prospective, Open-Label Study-Reference-Cited by-同舟云学术

Topical Ruxolitinib in the Treatment of Necrobiosis Lipoidica: A Prospective, Open-Label Study

Published:2024-09 Issue:9 Volume:144 Page:1994-2001.e4
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Hwang Angelina S.^ORCID,Kechter Jacob A.^ORCID,Li Xing^ORCID,Hughes Alysia^ORCID,Severson Kevin J.^ORCID,Boudreaux Blake^ORCID,Bhullar Puneet^ORCID,Nassir Shams^ORCID,Yousif Miranda^ORCID,Zhang Nan^ORCID,Butterfield Richard J.^ORCID,Nelson Steven^ORCID,Xing Xianying^ORCID,Tsoi Lam C.^ORCID,Zunich Samantha^ORCID,Sekulic Aleksandar^ORCID,Pittelkow Mark^ORCID,Gudjonsson Johann E.^ORCID,Mangold Aaron^ORCID

Funder

Incyte Corporation

Publisher

Elsevier BV

Reference43 articles.

1. Using the Skindex-16 and common terminology criteria for adverse events to assess rash symptoms: results of a pooled-analysis (N0993);Atherton;Support Care Cancer,2012

2. Intralesional infliximab in noninfectious cutaneous granulomas: three cases of necrobiosis lipoidica;Barde;Dermatology,2011

3. Necrobiosis lipoidica diabeticorum: response to pentoxiphylline;Basaria;J Endocrinol Invest,2003

4. Photodynamic therapy of necrobiosis lipoidica--a multicenter study of 18 patients;Berking;Dermatology,2009

5. Treatment of granuloma annulare with tofacitinib;Bosch-Amate;Australas J Dermatol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib for foreign body reaction to silicone in a patient with chronic graft‐versus‐host disease;International Journal of Dermatology;2024-07-04

2. Drug Repurposing Using Molecular Network Analysis Identifies Janus Kinase as Targetable Driver in Necrobiosis Lipoidica;JID Innovations;2024-06